Oudelaar, A. Marieke
Beagrie, Robert A. https://orcid.org/0000-0003-1076-5595
Gosden, Matthew https://orcid.org/0000-0002-0657-7666
de Ornellas, Sara https://orcid.org/0000-0002-7333-5456
Georgiades, Emily https://orcid.org/0000-0001-6356-0003
Kerry, Jon
Hidalgo, Daniel https://orcid.org/0000-0002-2615-2868
Carrelha, Joana
Shivalingam, Arun
El-Sagheer, Afaf H. https://orcid.org/0000-0001-8706-1292
Telenius, Jelena M.
Brown, Tom https://orcid.org/0000-0002-6538-3036
Buckle, Veronica J. https://orcid.org/0000-0003-1195-2608
Socolovsky, Merav https://orcid.org/0000-0001-6747-7960
Higgs, Douglas R. https://orcid.org/0000-0003-3579-8705
Hughes, Jim R. https://orcid.org/0000-0002-8955-7256
Funding for this research was provided by:
RCUK | Medical Research Council
Wellcome Trust
Article History
Received: 6 February 2020
Accepted: 13 May 2020
First Online: 1 June 2020
Competing interests
: J.R.H. is founder and shareholder of Nucleome Therapeutics.